Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Currently: BPC-157 is not FDA-approved There are no standardized treatment guidelines Long-term human safety data is lacking Large randomized clinical trials have not been completed Optimal dosing protocols have not been established Because most published research comes from animal studies, scientists cannot yet determine whether the same effects occur in humans
The peptide injections guide covers syringe technique in much greater detail, and the peptide dosing guide explains why precision at each draw matters for your results
If you miss a dose, take it as soon as possible within 4 days after your missed dose
A recent animal experiment in mice implanted with cancer cells found that adding BPC-157 did not meaningfully shrink the tumors
